INTRODUCTION 62
Exercise in individuals with COPD is limited by multiple factors which can result in 63 hypoxemia. These include loss of normal lung architecture, impaired cardiac function [1] , 64 abnormal pulmonary blood flow distribution [2] and peripheral muscle de-conditioning [3] . 65
Oxygen uptake in the lungs and delivery of oxygen to working muscle is impaired by 66 increases in pulmonary blood flow which increase shunting through blood vessels resulting in 67 incomplete gas exchange [4] and cor pulmonale later in the disease course. These 68 abnormalities result in feelings of breathlessness and fatigue [5] , with individuals often 69 finding that activities of daily living are physically challenging. 70
The beneficial effects of a diet rich in vegetables upon cardiovascular health [6] , risk 71 of morbidity and mortality [7] , and COPD development [8; 9] have been well described. 72
These positive effects have, in part, been attributed to inorganic nitrate which is found in 73 particularly high quantities in leafy green vegetables and some root vegetables such as 74 beetroot [10] . Nitrate supplementation in the form of sodium nitrate or nitrate-rich beetroot 75 juice has been shown to have remarkable effects in healthy young individuals and athletes, 76 including reductions in the oxygen cost of exercise [11] , enhanced exercise 77 tolerance/performance and reduced blood pressure (BP) [11; 12] . Some of these effects have 78 subsequently been observed in individuals with peripheral artery disease following dietary 79 nitrate supplementation [13] . These findings have been attributed to an increase in the 80 bioavailability of nitric oxide (NO). 81 NO is a signalling molecule with multiple functions including regulation of vascular 82 tone, mitochondrial respiration and skeletal muscle function [14; 15; 16] . These factors are 83 important in the physiological response to exercise. NO is produced in two distinct ways in 84 man. The best known is the classical L-arginine nitric oxide synthase (NOS) pathway which 85 is oxygen dependent [17] . The second is the entero-salivary pathway and is oxygen 86 independent. Briefly, nitrate from the diet is rapidly and extensively absorbed in the stomach 87 and proximal small intestine with bioavailability approaching 100% [18] to refrain from doing so for the duration of the study. 120
Pre-experimental tests 121
Participants arrived at the Heart and Lung unit at Torbay hospital where informed 122 consent, medical history, anthropometric measures, BP, lung function and an ECG were 123 performed. Participants completed a ramp incremental cycle ergometer test (10 W•min -1 ) to 124 determine their gas exchange threshold (GET). Breath-by-breath pulmonary gas exchange 125 was measured throughout and the GET was determined using the V-slope method as 126 described previously [23] . 127
Experimental Overview 128
Participants consumed 70 ml of nitrate-rich beetroot juice (beetroot juice; 6.77 mmol 129 nitrate; Beet it, James White Drinks Ltd., Ashbocking, UK) or nitrate-depleted beetroot juice 130 as a placebo (placebo; 0.002 mmol nitrate; Beet it, James White Drinks Ltd., Ashbocking, 131 UK), with one beverage in the morning and one in the evening for two days preceding 132 testing. On study days, participants consumed a final 70 ml beetroot juice drink ~3 hours 133 prior to exercising. Participants self-reported concordance with the supplementation regime 134 which was confirmed by measurement of plasma nitrate concentration. After exercise testing 135 the participants began a washout period (7 days) before entering the opposing arm of the 136 study. The placebo was indistinguishable from the nitrate-rich juice in taste, colour, texture, 137 appearance and odour as described previously [24] . 138
Participants arrived at the laboratory in a fully hydrated state, having avoided 139 consumption of caffeine, alcohol, cruciferous vegetables, leafy greens, beetroot, and 140 completion of strenuous exercise 24 hours prior to testing. Participants were asked to record 141 their food intake for 24 hours prior to testing and to replicate this after the crossover and this 142 was verbally confirmed on the second exercise visit. Participants avoided antibacterial 143 mouthwash for 7 days prior to testing. Participants arrived 45 minutes before the initiation of 144 exercise following ingestion of the randomised juice with their morning meal. Brachial artery 145 BP was taken, after a 10 minute resting period whilst supine, with an automated 146 sphygmomanometer (Omron M6, Kyoto, Japan). Five measurements were performed and the 147 mean of the last three was recorded. Venous blood was drawn and processed for plasma 148 nitrate concentration as per our previously described chemiluminescence technique [25] . 
Measurements 156
Pulmonary gas exchange and ventilation were measured during the cycling exercise 157 (Vmax TM Encore, Yorba, Linda, CA). Before each session the analysers were calibrated using 158 gases of known concentration. The volume transducer was calibrated using a 3-litre syringe 159 (Hans Rudolph, Kansas City, MO, USA). 160
Outcome measures 161
Primary outcome measure: does 2.5 days of nitrate supplementation reduce the 162 oxygen cost of moderate intensity cycling? Secondary outcome measure (i): does 2.5 days of 163 nitrate supplementation improve functional capacity as measured via the six-minute walk 164 test? Secondary outcome measure (ii): does 2.5 days of nitrate supplementation reduce 165 resting BP? 166
Sample size and randomisation 167
An a priori sample size calculation was performed. Previous literature in healthy 168 young volunteers has shown a mean change between beetroot juice and control of 69 ml for 169 end exercise pulmonary oxygen uptake (V̇O2) (1SD) and 121 ml for V̇O2 amplitude (2SD) 170
[11]. For 90% power and an α-level set at P=0.05 (two tailed), to detect a 1 SD difference 13 171 patients were required. The reproducibility of these measures in patients with COPD are 172 similar to healthy controls [26] . An unrestricted computer generated sequence was used by a 173 research nurse to assign each participant a randomisation number and supply them with the 174 requisite juice. 175
Data and statistical analysis 176
Participant's breath by breath V̇O2 data were initially checked for erroneous breaths 177 (caused by coughing and swallowing). Breaths > 4 SDs away from the local mean were 178 removed prior to interpolation. Breath by breath data for each cycling bout were time aligned 179 and interpolated to provide second by second values. A nonlinear least squares algorithm was 180 then used to fit the ensemble-averaged data. The overall V̇O2 kinetics were described using 181 the mean response time (MRT), which was calculated by fitting a single exponential curve to 182 the data with no time delay from the onset to the end of exercise. The oxygen deficit was 183 calculated as the product of the V̇O2 response amplitude (i.e. the baseline to the point that a 184 steady state was attained) and the MRT. For a schematic representation of the kinetics 185 parameters, please see figure 1 . 186
All data were tested for normality. Statistical differences were assessed using paired t-187 tests for normally distributed data and Wilcoxon rank-sum test for non-normally distributed 188 data. All data are presented as means ± standard deviation (SD 
Figure 2). 201
Effects on the oxygen cost of cycling exercise: The group mean pulmonary V̇O2 202 response to exercise for both placebo and beetroot juice conditions can be seen in figure 3 , 203 with the V̇O2 kinetics resulting from the model fits displayed in Table 2 . Relative to placebo, 204 beetroot juice supplementation had no effect on baseline V̇O2 (634 ± 233 vs. 622 ± 253 205 ml•min -1 , P = 0.56, 95% CI -57, 32) or end exercise V̇O2 (933 ± 323 vs. 939 ± 302 ml•min -206 1 , P = 0.88, 95% CI -68, 78). There were no differences between conditions for the MRT (P = 207 0.90, CI -25, 28) or the oxygen deficit (P = 0.71, CI -.2, .3) ( Table 2) . 208
Effects on functional capacity: There was no difference between conditions for 209 distance covered during the six-minute walk test (456 ± 86 vs. 449 ± 79 m, P = 0.17, 95% CI 210 -22, 9). 211
Effects on resting blood pressure: Compared to the placebo juice, beetroot juice did 212 not significantly reduce systolic BP (123 ± 14 vs. 123 ± 14 mmHg, P = 0.91, 95% CI -5, 4) or 213 diastolic BP (78 ± 9 vs. 79 ± 9 mmHg, P = 0.25, 95% CI -2, 5; Figure 4) . 
Nitrate supplementation and effects on functional capacity. 264
No statistical difference in distance covered for the six-minute walk test was 265 observed between conditions. Considering that the oxygen cost of exercise and rate of 266 adaptation of V̇O2 were not altered following nitrate supplementation, it is perhaps not 267 surprising that functional capacity was also not different between conditions. It is likely that 268 these lack of effects share a common explanation, which may be related to the impact of 269 oxidative stress on the bioavailability of NO [38] (see previous section). 270
The only other studies that have examined the impact of dietary nitrate 271 supplementation on walking performance have reported both positive and neutral effects. BP along with home and office based measurements were used to assess BP. They found no 302 reductions in BP or arterial stiffness. There are key differences around the supplementation 303 protocol and timing and method of blood pressure measurement. In Kelly et al's study the 304 office based blood pressure measurement was timed to coincide with the plasma nitrite peak 305 post nitrate ingestion. In the Bondonno et al study measurements took place outside this 306
window. 307
It is also worth noting the differing BMI's in these studies and our present manuscript. 308
Kelly et al's cohort of older adults are the only group in the normal range (24±3 kg/m 2 ). Our 309 present cohort had a mean BMI of 29 ± 8kg/m 2 , Bondonno et al's cohort were overweight 310 27±4 kg/m 2 , and in our previous study of subjects with type 2 diabetes the group mean BMI 311 was 30.8±3.2 kg/m 2 . This raises the possibility that adiposity may attenuate the response to 312 inorganic nitrate by an as yet unknown mechanism. 313
One factor which may have had an impact is that subjects in the present study were 314 taking multiple classes of drugs including antihypertensives. It is possible that the scope for 315 reductions in BP subsequent to nitrate supplementation is significantly reduced when 316 individuals are already taking antihypertensive medication. It is noteworthy that in studies 317 where subjects were taking antihypertensives (current study -38% prescribed This is the first double blind, randomised, placebo, controlled, crossover design 353 study to examine the effects of nitrate supplementation on the oxygen cost of exercise, 354 walking performance and BP in individuals with COPD. The study had a robust 355 experimental design (double-blind, placebo-controlled, randomised, cross-over study). A 356 limitation is that we were not able to ascertain whether or not the increase in plasma nitrate 357 concentration lead to an increase in plasma nitrite concentration, as we were not able to 358 measure the latter due to logistical constraints. However, a recent study examining nitrite 359 levels in individuals with COPD did show elevated plasma nitrite concentrations [44] which 360 suggests the entero-salivary pathway is operational. 361
Conclusion 362
In contrast to findings in healthy young individuals, and despite a statistically 363 significant and physiologically meaningful rise in plasma nitrate concentration, 2.5 days of 364 beetroot supplementation with 6.77 mmol of nitrate twice daily did not reduce the oxygen 365 cost of cycling exercise, improve functional capacity or reduce resting blood pressure. 366
Potential explanations for the lack of effect include a reduced P/O ratio due to systemic ROS 367 generation associated with oxidative stress, or a reduced conversion of nitrate to nitrite in this 368
population. 369
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